6-K

FASENRA PHASE III EGPA TRIAL MET PRIMARY ENDPOINT

Company: ASTRAZENECA PLC
Filed: September 11, 2023
Period of Report: September 11, 2023
Accession Number: 0001654954-23-011717

View Document ↗ View on SEC.gov ↗